Clinical Trial Update: A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing atezolizumab with bevacizumab versus sorafenib in untreated locally advanced or metastatic hepatocellular carcinoma has completed; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Carcinoma, Hepatocellular | Phase 3 | Status: COMPLETED | Results posted: 2021-11-05